Skip Navigation
Skip to contents
Filter

ARTICLE TYPE

PUBLICATION DATE

11 results
Display

Letter: Thyroid-Stimulating Hormone Reference Ranges in the First Trimester of Pregnancy in an Iodine-Sufficient Country (Endocrinol Metab 2018;33:466-72, Carmen Castillo et al.)

Kwon H

  • Endocrinol Metab.
  • 2019 Mar;34(1):93-94.
  • doi: 10.3803/EnM.2019.34.1.93
No abstract available.
Effects of Dipeptidyl Peptidase-4 Inhibitors on Renal Outcomes in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis

Bae JH, Kim S, Park EG, Kim SG, Hahn S, Kim NH

  • Endocrinol Metab.
  • 2019 Mar;34(1):80-92.
  • doi: 10.3803/EnM.2019.34.1.80
BACKGROUND: To investigate the effects of dipeptidyl peptidase-4 (DPP-4) inhibitors on renal outcomes in patients with type 2 diabetes. METHODS: MEDLINE, Embase, and the Cochrane Central Register of Controlled Trials were...
Retrospective Analysis of the Efficacy of Dapagliflozin in Patients with Type 2 Diabetes in a Primary Clinic in Korea

Park SH, Choi YJ, Rhee EJ, Huh KB

  • Endocrinol Metab.
  • 2019 Mar;34(1):70-79.
  • doi: 10.3803/EnM.2019.34.1.70
BACKGROUND: We aimed to retrospectively analyze the efficacy of 10 mg dapagliflozin (DAPA), which is a sodium-glucose cotransporter-2 inhibitor, in Korean patients with type 2 diabetes who visited a primary...
(99m)Tc-Pertechnetate Scintigraphy Predicts Successful Postoperative Ablation in Differentiated Thyroid Carcinoma Patients Treated with Low Radioiodine Activities

Giovanella L, Paone G, Ruberto T, Ceriani L, Trimboli P

  • Endocrinol Metab.
  • 2019 Mar;34(1):63-69.
  • doi: 10.3803/EnM.2019.34.1.63
BACKGROUND: Postoperative routine radioiodine (RAI) treatment is currently debated for patients with low-risk differentiated thyroid carcinoma (DTC) patients. If performed, a low 131I activity (i.e., 1 to 2 GBq) is...
Medical Treatment with Somatostatin Analogues in Acromegaly: Position Statement

Chin SO, Ku CR, Kim BJ, Kim SW, Park KH, Song KH, Oh S, Yoon HK, Lee EJ, Lee JM, Lim JS, Kim JH, Kim KJ, Jin HY, Kim DJ, Lee KA, Moon SS, Lim DJ, Shin DY, Kim SH, Kwon MJ, Kim HY, Kim JH, Kim DS, Kim CH

  • Endocrinol Metab.
  • 2019 Mar;34(1):53-62.
  • doi: 10.3803/EnM.2019.34.1.53
The Korean Endocrine Society (KES) published clinical practice guidelines for the treatment of acromegaly in 2011. Since then, the number of acromegaly cases, publications on studies addressing medical treatment of...
Myths about Insulin Resistance: Tribute to Gerald Reaven

Kim SH, Abbasi F

  • Endocrinol Metab.
  • 2019 Mar;34(1):47-52.
  • doi: 10.3803/EnM.2019.34.1.47
Gerald Reaven was often called the “father of insulin resistance.” On the 1-year anniversary of his death in 2018, we challenge three myths associated with insulin resistance: metformin improves insulin...
Implications of Mitochondrial Unfolded Protein Response and Mitokines: A Perspective on Fatty Liver Diseases

Yi HS

  • Endocrinol Metab.
  • 2019 Mar;34(1):39-46.
  • doi: 10.3803/EnM.2019.34.1.39
The signaling network of the mitochondrial unfolded protein response (UPR(mt)) and mitohormesis is a retrograde signaling pathway through which mitochondria-to-nucleus communication occurs in organisms. Recently, it has been shown that...
Graves' Disease: Can It Be Cured?

Wiersinga

  • Endocrinol Metab.
  • 2019 Mar;34(1):29-38.
  • doi: 10.3803/EnM.2019.34.1.29
Whether or not Graves' hyperthyroidism can be really cured, depends on the definition of “cure.” If eradication of thyroid hormone excess suffices for the label “cure,” then all patients can...
Search for Novel Mutational Targets in Human Endocrine Diseases

Park SY, Seo MH, Lee S

  • Endocrinol Metab.
  • 2019 Mar;34(1):23-28.
  • doi: 10.3803/EnM.2019.34.1.23
The identification of disease-causing genetic variations is an important goal in the field of genetics. Advancements in genetic technology have changed scientific knowledge and made it possible to determine the...
Mouse Models as a Tool for Understanding Progression in Braf(V600E)-Driven Thyroid Cancers

Landa I, Knauf JA

  • Endocrinol Metab.
  • 2019 Mar;34(1):11-22.
  • doi: 10.3803/EnM.2019.34.1.11
The development of next generation sequencing (NGS) has led to marked advancement of our understanding of genetic events mediating the initiation and progression of thyroid cancers. The NGS studies have...
Genomic Characterization of Differentiated Thyroid Carcinoma

Song YS, Park YJ

  • Endocrinol Metab.
  • 2019 Mar;34(1):1-10.
  • doi: 10.3803/EnM.2019.34.1.1
Since the release of The Cancer Genome Atlas study of papillary thyroid carcinoma (PTC) in 2014, additional genomic studies of differentiated thyroid carcinoma (DTC) using massively-parallel sequencing (MPS) have been...

Go to Top

Copyright © 2020 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr